In order to confirm the molecular mechanisms of HMGB1 inducing cancer cell dedifferentiation in vivo, we firstly determined the tumor initiation potential of CD133− cancer cells in similar in vitro conditions. This evidence concerns the gene HMGB1 and neoplasm.